Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)
Globe Newswire•01/09/2026•07:30 ET
0
Whiz Insights
Get started
Create a free account to read the full story.